General Information of the Compound
Compound ID |
CP0125184
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea
Show/Hide
|
||||||||||||||||||
Synonyms |
1095173-27-5
2640AH
AKOS027324121
BDBM50385635
CHEMBL2043437
CS-2
EX-A858
GTPL8201
Glasdegib
Glasdegib (PF-04449913)
Glasdegib (USAN/INN)
Glasdegib [USAN:INN]
Glasdegib(PF-04449913)
K673DMO5H9
MolPort-035-789-706
PF 04449913
PF-04449913
PF-04449913;Glasdegib
PF-913
SFNSLLSYNZWZQG-VQIMIIECSA-N
UNII-K673DMO5H9
ZINC68251434
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H22N6O
|
||||||||||||||||||
Molecular Weight |
374.448
|
||||||||||||||||||
Canonical SMILES |
CN1CC[C@H](C[C@@H]1c1nc2ccccc2[nH]1)NC(=O)Nc1ccc(cc1)C#N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28)/t16-,19-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SFNSLLSYNZWZQG-VQIMIIECSA-N
|
||||||||||||||||||
CAS |
1095173-27-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound